Zaiping Li

Title: Zaiping Li: Innovator in Biomedicine

Introduction

Zaiping Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedicine, particularly in the development of innovative therapeutic proteins. With a total of 4 patents, his work focuses on addressing critical health challenges, including cancer and liver injuries.

Latest Patents

One of Zaiping Li's latest patents is titled "Telomerase activity inhibiting peptide and manufacturing method and application thereof." This invention provides a telomerase activity inhibiting polypeptide that can significantly inhibit tumor cell telomerase activity and growth, ultimately leading to the death of tumor cells. The patent also outlines a preparation method for the polypeptide and its application in targeted tumor treatments. Another notable patent is "Human liver regeneration associated protein and the use thereof." This invention introduces a novel human liver regeneration associated protein, hLRTM4, along with the polynucleotide encoding it. The hLRTM4 protein can be utilized to treat liver injuries, and its antagonists can be employed in the treatment of hepatocellular carcinoma, along with corresponding pharmaceutical compositions.

Career Highlights

Zaiping Li has worked with esteemed institutions such as the Chinese Academy of Sciences and the Shanghai Institutes for Biological Sciences. His research has significantly advanced the understanding and treatment of various medical conditions.

Collaborations

Throughout his career, Zaiping Li has collaborated with notable colleagues, including Mujun Zhao and Zhanwu Liu. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Zaiping Li's contributions to biomedicine through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in targeted therapies for critical health issues.